85 research outputs found
Comentarios sobre toxicidad por reabsorción de anestésico local en vía aérea difícil prevista
Comentarios sobre toxicidad por reabsorción de anestésico local en vía aérea difícil prevista
Usefulness of myocardial circunferential strain in acute myocardial infarction for prediction of contractile function recovery: a MRI myocardial tagging study
3D visualization of myocardial substrate using Delayed Enhancement MRI for pre-planning and guidance of ablation procedures of ventricular tachycardia
Diferencias en el sustrato endo y epicárdico de las taquicardias ventriculares posinfarto analizado mediante resonancia magnética cardiaca con realce tardío
Algunas taquicardias ventriculares (TV) posinfarto se localizan en el epicardio. La identificación de diferencias en el sustrato de las TV endocárdicas y epicárdicas permitiría definir una mejor estrategia de ablación
The ERICE-score: the new native cardiovascular score for the low-risk and aged mediterranean population of Spain
[Abstract] Introduction and objectives. In Spain, data based on large population-based cohorts adequate to provide an accurate prediction of cardiovascular risk have been scarce. Thus, calibration of the EuroSCORE and Framingham scores has been proposed and done for our population. The aim was to develop a native risk prediction score to accurately estimate the individual cardiovascular risk in the Spanish population.
Methods. Seven Spanish population-based cohorts including middle-aged and elderly participants were assembled. There were 11 800 people (6387 women) representing 107 915 person-years of follow-up. A total of 1214 cardiovascular events were identified, of which 633 were fatal. Cox regression analyses were conducted to examine the contributions of the different variables to the 10-year total cardiovascular risk.
Results. Age was the strongest cardiovascular risk factor. High systolic blood pressure, diabetes mellitus and smoking were strong predictive factors. The contribution of serum total cholesterol was small. Antihypertensive treatment also had a significant impact on cardiovascular risk, greater in men than in women. The model showed a good discriminative power (C-statistic = 0.789 in men and C = 0.816 in women). Ten-year risk estimations are displayed graphically in risk charts separately for men and women.
Conclusions. The ERICE is a new native cardiovascular risk score for the Spanish population derived from the background and contemporaneous risk of several Spanish cohorts. The ERICE score offers the direct and reliable estimation of total cardiovascular risk, taking in consideration the effect of diabetes mellitus and cardiovascular risk factor management. The ERICE score is a practical and useful tool for clinicians to estimate the total individual cardiovascular risk in Spain.[Resumen] Introducción y objetivos. En España no existen unas cohortes poblacionales suficientemente grandes para hacer predicciones precisas del riesgo cardiovascular. Las ecuaciones de Framingham y EuroSCORE calibradas son las más utilizadas en España. El objetivo es desarrollar la primera ecuación de predicción autóctona para estimar con precisión el riesgo cardiovascular individual en España.
Métodos. Análisis conjunto de siete cohortes españolas de población de mediana edad y anciana. La población del estudio —11.800 personas (6.387 mujeres)— aportó un total de 107.915 personas-año de seguimiento y 1.214 eventos cardiovasculares (633 de ellos, mortales). Se efectuó un análisis de regresión de Cox para examinar la contribución de los diferentes factores al riesgo de cualquier evento cardiovascular (mortal y no mortal).
Resultados. La edad fue el principal factor de riesgo de eventos cardiovasculares. La presión arterial sistólica, la diabetes mellitus, el tabaquismo y el tratamiento antihipertensivo fueron factores predictivos fuertemente asociados con el riesgo cardiovascular. En cambio, la contribución del colesterol total sérico fue pequeña, especialmente en los mayores de 70 años. El modelo final de riesgo mostró un buen poder discriminatorio (estadístico C = 0,789 en varones y C = 0,816 en mujeres).
Conclusiones. ERICE es una nueva ecuación de riesgo cardiovascular genuinamente española obtenida a partir del riesgo concurrente individual de los participantes en varias cohortes. La ecuación ERICE ofrece una estimación directa y fiable del riesgo cardiovascular total teniendo en cuenta factores como la diabetes mellitus y el tratamiento farmacológico de los factores de riesgo cardiovascular, habitualmente no incluidos en otras ecuaciones.Instituto de Salud Carlos III; G03/065Instituto de Salud Carlos III; PI05/1464Instituto de Salud Carlos III; RD06/0014/001
Algoritmo Level-set para segmentación hepática en TAC con Restricciones de curvatura local
Actas de: XXIX Congreso Anual de la Sociedad Espñaola de Ingeniería Biomédica (CASEIB 2011). Cáceres, 16-18 Noviembre 2011.La cirugía hepática avanzada requiere de una precisa planificación pre-operatoria en la que tanto la segmentación anatómica como la estimación del volumen hepático remanente tienen una importancia clave a la hora de evitar un fallo hepático postoperatorio. En este contexto, algoritmos basados en level-sets han logrado mejores resultados que otros, especialmente cuando se tratan casos con un parénquima hepático alterado o en hígados previamente resecados. Con el objetivo de mejorar las medidas de volumen hepático funcional, se proponen dos estrategias para completar y realzar algoritmos previos basados en level-sets: una estrategia optimizada multi-resolución con curvatura adaptativa y corrección/refinamiento de detalles, junto con un paso semiautomático adicional en el que se imponen restricciones de curvatura local. Los resultados muestran segmentaciones robustas y precisas, especialmente en estructuras alargadas, detectando lesiones internas y evitando fugas o escapes a estructuras proximales.Este trabajo está parcialmente apoyado por los proyectos de investigación PI09/91058, PI09/91065, ENTEPRASE PS-300000-2009-5, AMIT-CDTI, TEC2010-21619-C04 and PRECISION IPT-300000-2010-3, del Ministerio de Ciencia e Innovación de España, el proyecto ARTEMIS de la Comunidad de Madrid y la ayuda de los fondos FEDER de la Unión Europea.Publicad
Intraoperative computed tomography imaging for dose calculation in intraoperative electron radiation therapy: Initial clinical observations
In intraoperative electron radiation therapy (IOERT) the energy of the electron beam is selected under the conventional assumption of water-equivalent tissues at the applicator end. However, the treatment field can deviate from the theoretic flat irradiation surface, thus altering dose profiles. This patient-based study explored the feasibility of acquiring intraoperative computed tomography (CT) studies for calculating three-dimensional dose distributions with two factors not included in the conventional assumption, namely the air gap from the applicator end to the irradiation surface and tissue heterogeneity. In addition, dose distributions under the conventional assumption and from preoperative CT studies (both also updated with intraoperative data) were calculated to explore whether there are other alternatives to intraoperative CT studies that can provide similar dose distributions. The IOERT protocol was modified to incorporate the acquisition of intraoperative CT studies before radiation delivery in six patients.This study was supported by Ministerio de Ciencia, Innovación y Universidades (http://www.ciencia.gob.es) [grant number TEC2013–48251-C2 to JP, VG-V and MJL-C], co-funded by European Regional Development Fund (ERDF), “A way of making Europe” (https://ec.europa.eu/regional_policy/en/funding/erdf); by Ministerio de Ciencia, Innovación y Universidades (http://www.ciencia.gob.es), Instituto de Salud Carlos III (https://www.isciii.es) [grant numbers DTS14/00192 to JP, VG-V and FAC; PI15/02121 to FAC and JC-H; PI18/01625 to JP], co-funded by European Regional Development Fund (ERDF), “A way of making Europe” (https://ec.europa.eu/regional_policy/en/funding/erdf); and by Comunidad de Madrid (http://www.comunidad.madrid) [grant number TOPUS-CM S2013/MIT3024 to JP], co-funded by European Structural and Investment Fund (https://ec.europa.eu/info/funding-tenders/funding-opportunities/funding-programmes/overview-funding-programmes_en). The CNIC is supported by the Ministerio de Ciencia, Innovación y Universidades (http://www.ciencia.gob.es) and the Pro CNIC Foundation (https://www.fundacionprocnic.es) [to MD], and is a Severo Ochoa Center of Excellence (SEV-2015-0505). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript
Identification of prefoldin amplification (1q23.3-q24.1) in bladder cancer using comparative genomic hybridization (CGH) arrays of urinary DNA
Background: Array-CGH represents a comprehensive tool to discover genomic disease alterations that could potentially be applied to body fluids. In this report, we aimed at applying array-CGH to urinary samples to characterize bladder cancer. Methods: Urinary DNA from bladder cancer patients and controls were hybridized on 44K oligonucleotide arrays. Validation analyses of identified regions and candidates included fluorescent in situ hybridization (FISH) and immunohistochemistry in an independent set of bladder tumors spotted on custom-made tissue arrays (n = 181). Results: Quality control of array-CGH provided high reproducibility in dilution experiments and when comparing reference pools. The most frequent genomic alterations (minimal recurrent regions) among bladder cancer urinary specimens included gains at 1q and 5p, and losses at 10p and 11p. Supervised hierarchical clustering identified the gain at 1q23.3-q24.1 significantly correlated to stage (p = 0.011), and grade (p = 0.002). The amplification and overexpression of Prefoldin (PFND2), a selected candidate mapping to 1q23.3-q24.1, correlated to increasing stage and tumor grade by means of custom-designed and optimized FISH (p = 0.013 and p = 0.023, respectively), and immunohistochemistry (p ≤0.0005 and p = 0.011, respectively), in an independent set of bladder tumors included in tissue arrays. Moreover, PFND2 overexpression was significantly associated with poor disease-specific survival (p ≤0.0005). PFND2 was amplified and overexpressed in bladder tumors belonging to patients providing urinary specimens where 1q23.3q24.1 amplification was detected by array-CGH. Conclusions: Genomic profiles of urinary DNA mirrowed bladder tumors. Molecular profiling of urinary DNA using array-CGH contributed to further characterize genomic alterations involved in bladder cancer progression. PFND2 was identified as a tumor stratification and clinical outcome prognostic biomarker for bladder cancer patients
Liver Segmentation and Volume Estimation from Preoperative CT Images in Hepatic Surgical Planning: Application of a Semiautomatic Method Based on 3D Level Sets
Identification of prefoldin amplification (1q23.3-q24.1) in bladder cancer using comparative genomic hybridization (CGH) arrays of urinary DNA
Array-CGH represents a comprehensive tool to discover genomic disease alterations that could
potentially be applied to body fluids. In this report, we aimed at applying array-CGH to urinary samples to
characterize bladder cancer.
Methods: Urinary DNA from bladder cancer patients and controls were hybridized on 44K oligonucleotide arrays.
Validation analyses of identified regions and candidates included fluorescent in situ hybridization (FISH) and
immunohistochemistry in an independent set of bladder tumors spotted on custom-made tissue arrays (n = 181).
Results: Quality control of array-CGH provided high reproducibility in dilution experiments and when comparing
reference pools. The most frequent genomic alterations (minimal recurrent regions) among bladder cancer urinary
specimens included gains at 1q and 5p, and losses at 10p and 11p. Supervised hierarchical clustering identified the
gain at 1q23.3-q24.1 significantly correlated to stage (p = 0.011), and grade (p = 0.002). The amplification and
overexpression of Prefoldin (PFND2), a selected candidate mapping to 1q23.3-q24.1, correlated to increasing
stage and tumor grade by means of custom-designed and optimized FISH (p = 0.013 and p = 0.023,
respectively), and immunohistochemistry (p ≤0.0005 and p = 0.011, respectively), in an independent set of
bladder tumors included in tissue arrays. Moreover, PFND2 overexpression was significantly associated with poor
disease-specific survival (p ≤0.0005). PFND2 was amplified and overexpressed in bladder tumors belonging to
patients providing urinary specimens where 1q23.3q24.1 amplification was detected by array-CGH.
Conclusions: Genomic profiles of urinary DNA mirrowed bladder tumors. Molecular profiling of urinary DNA
using array-CGH contributed to further characterize genomic alterations involved in bladder cancer progression.
PFND2 was identified as a tumor stratification and clinical outcome prognostic biomarker for bladder cancer
patientsSupported by grants (SAF2009-13035 and SAF2012-40206) from the Spanish
Ministry of Education and Culture (to Dr Sánchez-Carbayo). Virginia López is
recipient of a predoctoral award from the Spanish Ministry of Education and
Cultur
- …